ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 26 filers reported holding ACER THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20 | -13.0% | 24 | 0.0% | 0.00% | – |
Q2 2023 | $23 | +21.1% | 24 | 0.0% | 0.00% | – |
Q1 2023 | $19 | -68.3% | 24 | 0.0% | 0.00% | – |
Q4 2022 | $60 | – | 24 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 24 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 24 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 24 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 24 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 24 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 24 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 24 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 24 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nantahala Capital Management | 1,136,416 | $1,049,367 | 0.10% |
Anson Funds Management LP | 129,795 | $119,853 | 0.02% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 60,000 | $55 | 0.01% |
Hudson Bay Capital Management LP | 274,300 | $253,289 | 0.00% |
UBS Group AG | 33 | $30 | 0.00% |
RHUMBLINE ADVISERS | 347 | $320 | 0.00% |
OSAIC HOLDINGS, INC. | 200 | $184 | 0.00% |
WELLS FARGO & COMPANY/MN | 132 | $122 | 0.00% |
NORTHERN TRUST CORP | 22,231 | $20,528 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |